Functional genetic variation in NFKBIA and susceptibility to childhood asthma, bronchiolitis, and bronchopulmonary dysplasia

Journal of Immunology

Volumn 190, Issue 8, 2013, Pages 3949-3958

  Ali, Salman ^a   Hirschfeld, Aaron F ^a   Mayer, Matthew L ^a   Fortuno III, Edgardo S ^a   Corbett, Nathan ^a   Kaplan, Maia ^a   Wang, Shirley ^a   Schneiderman, Julia ^a   Fjell, Christopher D ^a   Yan, Jin ^b   Akhabir, Loubna ^b   Aminuddin, Farzian ^b   Marr, Nico ^a   Lacaze Masmonteil, Thierry ^c   Hegele, Richard G ^d   Becker, Allan ^e   Chan Yeung, Moira ^a   Hancock, Robert E W ^a   Kollmann, Tobias R ^a   Daley, Denise ^b   Sandford, Andrew J ^b   Lavoie, Pascal M ^a   Turvey, Stuart E ^a,f   more..

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ST PAUL S HOSPITAL   (Canada)

^c CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF MANITOBA   (Canada)

^f BC CHILDREN S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B ALPHA; MESSENGER RNA; TOLL LIKE RECEPTOR;

ALLELE; ARTICLE; ASTHMA; BRONCHIOLITIS; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE; GENE EXPRESSION; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; INNATE IMMUNITY; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; NEWBORN; NFKBIA GENE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RESPIRATORY TRACT ALLERGY; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; ASTHMA; BRONCHIOLITIS; BRONCHOPULMONARY DYSPLASIA; CHILD; CHILD, PRESCHOOL; CHO CELLS; CRICETINAE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; INFANT; INFANT, NEWBORN; NF-KAPPA B P50 SUBUNIT; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RESPIRATORY SYNCYTIAL VIRUSES;

EID: 84876008900     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201015     Document Type: Article

References (63)

1. British Thoracic Society. 2006. The Burden of Lung Disease, 2nd Ed. British Thoracic Society, London.
2. Turvey, S. E., and D. H. Broide. 2010. Innate immunity. J. Allergy Clin. Immunol. 125(2, Suppl 2)S24-S32.
3. Hayden, M. S., and S. Ghosh. 2008. Shared principles in NF-kappaB signaling. Cell 132: 344-362.
4. Beg, A. A., W. C. Sha, R. T. Bronson, and D. Baltimore. 1995. Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alpha-deficient mice. Genes Dev. 9: 2736-2746.
5. Courtois, G., A. Smahi, J. Reichenbach, R. Döffinger, C. Cancrini, M. Bonnet, A. Puel, C. Chable-Bessia, S. Yamaoka, J. Feinberg, et al. 2003. A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ecto-dermal dysplasia and T cell immunodeficiency. J. Clin. Invest. 112: 1108-1115.
6. Zhang, G. L., Y. F. Zou, X. L. Feng, H. J. Shi, X. F. Du, M. H. Shao, Y. Gu, and Q. Zhou. 2011. Association of the NFKBIA gene polymorphisms with susceptibility to autoimmune and inflammatory diseases: a meta-analysis. Inflamm. Res. 60: 11-18.
7. Rogers, A. J., B. A. Raby, J. A. Lasky-Su, A. Murphy, R. Lazarus, B. J. Klanderman, J. S. Sylvia, J. P. Ziniti, C. Lange, J. C. Celedón, et al. 2009. Assessing the reproducibility of asthma candidate gene associations, using genome-wide data. Am. J. Respir. Crit. Care Med. 179: 1084-1090.
8. Schlender, J., V. Hornung, S. Finke, M. Günthner-Biller, S. Marozin, K. Brzózka, S. Moghim, S. Endres, G. Hartmann, and K. K. Conzelmann. 2005. Inhibition of toll-like receptor 7- and 9-mediated alpha/beta interferon production in human plasmacytoid dendritic cells by respiratory syncytial virus and measles virus. J. Virol. 79: 5507-5515.
9. Liu, P., M. Jamaluddin, K. Li, R. P. Garofalo, A. Casola, and A. R. Brasier. 2007. Retinoic acid-inducible gene I mediates early antiviral response and Toll-like receptor 3 expression in respiratory syncytial virus-infected airway epithelial cells. J. Virol. 81: 1401-1411.
10. Murawski, M. R., G. N. Bowen, A. M. Cerny, L. J. Anderson, L. M. Haynes, R. A. Tripp, E. A. Kurt-Jones, and R. W. Finberg. 2009. Respiratory syncytial virus activates innate immunity through Toll-like receptor 2. J. Virol. 83: 1492-1500.
11. Rudd, B. D., E. Burstein, C. S. Duckett, X. Li, and N. W. Lukacs. 2005. Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression. J. Virol. 79: 3350-3357.
12. Soucy-Faulkner, A., E. Mukawera, K. Fink, A. Martel, L. Jouan, Y. Nzengue, D. Lamarre, C. Vande Velde, and N. Grandvaux. 2010. Requirement of NOX2 and reactive oxygen species for efficient RIG-I-mediated antiviral response through regulation of MAVS expression. PLoS Pathog. 6: e1000930.
13. Jobe, A. H., and E. Bancalari. 2001. Bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med. 163: 1723-1729.
14. Karin, M., Y. Yamamoto, and Q. M. Wang. 2004. The IKK NF-kappa B system: a treasure trove for drug development. Nat. Rev. Drug Discov. 3: 17-26.
15. Hirschfeld, A. F., J. A. Bettinger, R. E. Victor, D. J. Davidson, A. J. Currie, J. M. Ansermino, D. W. Scheifele, J. S. Orange, and S. E. Turvey. 2007. Prevalence of Toll-like receptor signalling defects in apparently healthy children who developed invasive pneumococcal infection. Clin. Immunol. 122: 271-278.
16. Zhu, G., R. H. Lipsky, K. Xu, S. Ali, T. Hyde, J. Kleinman, L. A. Akhtar, D. C. Mash, and D. Goldman. 2004. Differential expression of human COMT alleles in brain and lymphoblasts detected by RT-coupled 59 nuclease assay. Psychopharmacology (Berl.) 177: 178-184.
17. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
18. Kollmann, T. R., J. Crabtree, A. Rein-Weston, D. Blimkie, F. Thommai, X. Y. Wang, P. M. Lavoie, J. Furlong, E. S. Fortuno, III, A. M. Hajjar, et al. 2009. Neonatal innate TLR-mediated responses are distinct from those of adults. J. Immunol. 183: 7150-7160.
19. Corbett, N. P., D. Blimkie, K. C. Ho, B. Cai, D. P. Sutherland, A. Kallos, J. Crabtree, A. Rein-Weston, P. M. Lavoie, S. E. Turvey, et al. 2010. Ontogeny of Toll-like receptor mediated cytokine responses of human blood mononuclear cells. PLoS ONE 5: e15041.
20. Jansen, K., D. Blimkie, J. Furlong, A. Hajjar, A. Rein-Weston, J. Crabtree, B. Reikie, C. Wilson, and T. Kollmann. 2008. Polychromatic flow cytometric high-throughput assay to analyze the innate immune response to Toll-like receptor stimulation. J. Immunol. Methods 336: 183-192.
21. Davis, S., and P. S. Meltzer. 2007. GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor. Bioinformatics 23: 1846-1847.
22. Bolstad, B. M., R. A. Irizarry, M. Astrand, and T. P. Speed. 2003. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19: 185-193.
23. Smyth, G. K. 2004. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3: Article3.
24. Benjamini, Y., and Y. Hochberg. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57: 289-300.
25. Mayer, M. L., J. A. Sheridan, C. J. Blohmke, S. E. Turvey, and R. E. Hancock. 2011. The Pseudomonas aeruginosa autoinducer 3O-C12 homoserine lactone provokes hyperinflammatory responses from cystic fibrosis airway epithelial cells. PLoS ONE 6: e16246.
26. Lynn, D. J., G. L. Winsor, C. Chan, N. Richard, M. R. Laird, A. Barsky, J. L. Gardy, F. M. Roche, T. H. Chan, N. Shah, et al. 2008. InnateDB: facilitating systems-level analyses of the mammalian innate immune response. Mol. Syst. Biol. 4: 218.
27. Smoot, M. E., K. Ono, J. Ruscheinski, P. L. Wang, and T. Ideker. 2011. Cyto-scape 2.8: new features for data integration and network visualization. Bio-informatics 27: 431-432.
28. Cline, M. S., M. Smoot, E. Cerami, A. Kuchinsky, N. Landys, C. Workman, R. Christmas, I. Avila-Campilo, M. Creech, B. Gross, et al. 2007. Integration of biological networks and gene expression data using Cytoscape. Nat. Protoc. 2: 2366-2382.
29. Barsky, A., J. L. Gardy, R. E. Hancock, and T. Munzner. 2007. Cerebral: a Cytoscape plugin for layout of and interaction with biological networks using subcellular localization annotation. Bioinformatics 23: 1040-1042.
30. Lin, C. Y., C. H. Chin, H. H. Wu, S. H. Chen, C. W. Ho, and M. T. Ko. 2008. Hubba: hub objects analyzer - a framework of interactome hubs identification for network biology. Nucleic Acids Res. 36: W438-443.
31. Paulus, S. C., A. F. Hirschfeld, R. E. Victor, J. Brunstein, E. Thomas, and S. E. Turvey. 2007. Common human Toll-like receptor 4 polymorphisms-role in susceptibility to respiratory syncytial virus infection and functional immu-nological relevance. Clin. Immunol. 123: 252-257.
32. Daley, D., M. Lemire, L. Akhabir, M. Chan-Yeung, J. Q. He, T. McDonald, A. Sandford, D. Stefanowicz, B. Tripp, D. Zamar, et al. 2009. Analyses of associations with asthma in four asthma population samples from Canada and Australia. Hum. Genet. 125: 445-459.
33. Chan-Yeung, M., J. Manfreda, H. Dimich-Ward, A. Ferguson, W. Watson, and A. Becker. 2000. A randomized controlled study on the effectiveness of a multifaceted intervention program in the primary prevention of asthma in high-risk infants. Arch. Pediatr. Adolesc. Med. 154: 657-663.
34. Chan-Yeung, M., A. Ferguson, W. Watson, H. Dimich-Ward, R. Rousseau, M. Lilley, A. Dybuncio, and A. Becker. 2005. The Canadian Childhood Asthma Primary Prevention Study: outcomes at 7 years of age. J. Allergy Clin. Immunol. 116: 49-55.
35. Lee, K. K., R. G. Hegele, J. Manfreda, K. Wooldrage, A. B. Becker, A. C. Ferguson, H. Dimich-Ward, W. T. Watson, and M. Chan-Yeung. 2007. Relationship of early childhood viral exposures to respiratory symptoms, onset of possible asthma and atopy in high risk children: the Canadian Asthma Primary Prevention Study. Pediatr. Pulmonol. 42: 290-297.
36. Lavoie, P. M., C. Pham, and K. L. Jang. 2008. Heritability of bronchopulmonary dysplasia, defined according to the consensus statement of the national institutes of health. Pediatrics 122: 479-485.
37. Chapman, S. J., C. C. Khor, F. O. Vannberg, A. Frodsham, A. Walley, N. A. Maskell, C. W. Davies, S. Segal, C. E. Moore, S. H. Gillespie, et al. 2007. IkappaB genetic polymorphisms and invasive pneumococcal disease. Am. J. Respir. Crit. Care Med. 176: 181-187.
38. Mozzato-Chamay, N., E. L. Corbett, R. L. Bailey, D. C. Mabey, J. Raynes, and D. J. Conway. 2001. Polymorphisms in the IkappaB-alpha promoter region and risk of diseases involving inflammation and fibrosis. Genes Immun. 2: 153-155.
39. Kawai, T., S. Sato, K. J. Ishii, C. Coban, H. Hemmi, M. Yamamoto, K. Terai, M. Matsuda, J. Inoue, S. Uematsu, et al. 2004. Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat. Immunol. 5: 1061-1068.
40. Wang, X., S. Hussain, E. J. Wang, X. Wang, M. O. Li, A. García-Sastre, and A. A. Beg. 2007. Lack of essential role of NF-kappa B p50, RelA, and cRel subunits in virus-induced type 1 IFN expression. J. Immunol. 178: 6770-6776.
41. Zaas, A. K., M. Chen, J. Varkey, T. Veldman, A. O. Hero, III, J. Lucas, Y. Huang, R. Turner, A. Gilbert, R. Lambkin-Williams, et al. 2009. Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans. Cell Host Microbe 6: 207-217.
42. Laprise, C, R. Sladek, A Ponton, M. C. Bernier, T. J. Hudson, and M. Laviolette. 2004. Functional classes of bronchial mucosa genes that are differentially expressed in asthma. BMC Genomics 5: 21.
43. Cohen, J., L. J. Van Marter, Y Sun, E. Allred, A. Leviton, and I. S. Kohane. 2007. Perturbation of gene expression of the chromatin remodeling pathway in premature newborns at risk for bronchopulmonary dysplasia. Genome Biol. 8: R210.
44. Klement, J. F, N. R. Rice, B. D. Car, S. J. Abbondanzo, G. D. Powers, P. H. Bhatt, C. H. Chen, C. A. Rosen, and C. L. Stewart. 1996. IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice. Mol. Cell. Biol. 16: 2341-2349.
45. Ovsyannikova, I. G., I. H. Haralambieva, R. A. Vierkant, V S. Pankratz, R. M. Jacobson, and G A. Poland. 2011. The role of polymorphisms in Toll-like receptors and their associated intracellular signaling genes in measles vaccine immunity. Hum. Genet. 130: 547-561.
46. Paterson, R. L., H. F Galley, J. K. Dhillon, and N. R. Webster. 2000. Increased nuclear factor kappa B activation in critically ill patients who die. Crit. Care Med. 28: 1047-1051.
47. Bohrer, H., F. Qiu, T. Zimmermann, Y. Zhang, T. Jllmer, D. Männel, B. W. Böttiger, D. M. Stern, R. Waldherr, H. D. Saeger, et al. 1997. Role of NFkappaB in the mortality of sepsis. J. Clin. Invest. 100: 972-985.
48. Welliver, R. C, Sr. 2008. The immune response to respiratory syncytial virus infection: friend or foe? Clin. Rev. Allergy Immunol. 34: 163-173.
49. Hacking, D., J. C. Knight, K. Rockett, H. Brown, J. Frampton, D. P. Kwiatkowski, J. Hull, and I. A. Udalova. 2004. Increased in vivo transcription of an IL-8 haplotype associated with respiratory syncytial virus disease-susceptibility. Genes Immun. 5: 274-282.
50. Sigurs, N., P. M. Gustafsson, R. Bjarnason, F. Lundberg, S. Schmidt, F Sigurbergsson, and B. Kjellman. 2005. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am. J. Respir. Crit. Care Med. 171: 137-141.
51. Stensballe, L. G., J. B. Simonsen, S. F Thomsen, A. M. Larsen, S. H. Lysdal, P. Aaby, K. O. Kyvik, A. Skytthe, V Backer, and H. Bisgaard. 2009. The causal direction in the association between respiratory syncytial virus hospitalization and asthma. J. Allergy Clin. Immunol. 123: 131-137.e1.
52. Baraldi, E., and M. Filippone. 2007. Chronic lung disease after premature birth. N. Engl. J. Med. 357: 1946-1955.
53. Boyce, T. G., B. G. Mellen, E. F Mitchel, Jr., P. F Wright, and M. R. Griffin. 2000. Rates of hospitalization for respiratory syncytial virus infection among children in medicaid. J. Pediatr. 137: 865-870.
54. Schanzer, D. L., J. M. Langley, and T. W. Tam. 2006. Hospitalization attributable to influenza and other viral respiratory illnesses in Canadian children. Pediatr. Infect. Dis. J. 25: 795-800.
55. Bhandari, V, M. J. Bizzarro, A. Shetty, X. Zhong, G. P. Page, H. Zhang, L. R. Ment, and J. R. Gruen; Neonatal Genetics Study Group. 2006. Familial and genetic susceptibility to major neonatal morbidities in preterm twins. Pediatrics 117: 1901-1906.
56. Correa, P. A, L. M. Gomez, J. Cadena, and J. M. Anaya. 2005. Autoimmunity and tuberculosis. Opposite association with TNF polymorphism. J. Rheumatol. 32: 219-224.
57. Siezen, C. L., L. Bont, H. M. Hodemaekers, M. J. Ermers, G. Doornbos, R. Van't Slot, C. Wijmenga, H. C. Houwelingen, J. L. Kimpen, T. G. Kimman, et al. 2009. Genetic susceptibility to respiratory syncytial virus bronchiolitis in preterm children is associated with airway remodeling genes and innate immune genes. Pediatr. Infect. Dis. J. 28: 333-335.
58. Zhai, R., W. Zhou, M. N. Gong, B. T. Thompson, L. Su, C. Yu, P. Kraft, and D. C. Christiani. 2007. Inhibitor kappaB-alpha haplotype GTC is associated with susceptibility to acute respiratory distress syndrome in Caucasians. Crit. Care Med. 35: 893-898.
59. Kurylowicz, A, P. Miskiewicz, E. Bar-Andziak, J. Nauman, and T. Bednarczuk. 2009. Association of polymorphism in genes encoding kappaB inhibitors (IkappaB) with susceptibility to and phenotype of Graves' disease: a case-control study. Thyroid Res. 2: 10.
60. Lin, C. H., T. T. Ou, C. C. Wu, W. C. Tsai, H. W. Liu, and J. H. Yen. 2007. IkappaBalpha promoter polymorphisms in patients with rheumatoid arthritis. Int. J. Immunogenet. 34: 51-54.
61. Abdallah, A., H. Sato, J. C. Grutters, S. Veeraraghavan, P. A. Lympany, H. J. Ruven, J. M. van den Bosch, A. U. Wells, R. M. du Bois, and K. I. Welsh. 2003. Inhibitor kappa B-alpha (IkappaB-alpha) promoter polymorphisms in UK and Dutch sarcoidosis. Genes Immun. 4: 450-454.
62. Spink, C. F, L. C. Gray, F E. Davies, G. J. Morgan, and J. L. Bidwell. 2007. Haplotypic structure across the I kappa B alpha gene (NFKBIA) and association with multiple myeloma. Cancer Lett. 246: 92-99.
63. He, Y, H. Zhang, J. Yin, J. Xie, X. Tan, S. Liu, Q. Zhang, C. Li, J. Zhao, H. Wang, and G. Cao. 2009. IkappaBalpha gene promoter polymorphisms are associated with hepatocarcinogenesis in patients infected with hepatitis B virus genotype C. Carcinogenesis 30: 1916-1922.